Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 214.13B | 192.99B | 176.92B | 168.53B | 163.56B |
Gross Profit | 51.59B | 45.69B | 43.35B | 42.31B | 41.84B |
EBITDA | 10.27B | 9.67B | 8.48B | 9.45B | 8.75B |
Net Income | 4.94B | 5.17B | 3.82B | 5.25B | 4.86B |
Balance Sheet | |||||
Total Assets | 70.69B | 61.87B | 57.20B | 54.15B | 51.39B |
Cash, Cash Equivalents and Short-Term Investments | 16.87B | 17.14B | 15.69B | 17.03B | 16.26B |
Total Debt | 14.01B | 9.17B | 9.30B | 9.30B | 9.30B |
Total Liabilities | 38.12B | 31.90B | 30.45B | 29.40B | 30.13B |
Stockholders Equity | 32.57B | 29.97B | 26.76B | 24.59B | 21.10B |
Cash Flow | |||||
Free Cash Flow | 3.72B | 3.52B | 1.29B | 2.76B | 6.72B |
Operating Cash Flow | 7.51B | 7.39B | 3.96B | 5.63B | 9.31B |
Investing Cash Flow | -8.84B | -4.00B | -3.31B | -3.25B | -2.97B |
Financing Cash Flow | 999.00M | -1.94B | -2.00B | -1.62B | -6.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥66.17B | 12.35 | 1.52% | 17.13% | -6.33% | ||
79 Outperform | ¥60.51B | 11.65 | 2.96% | 12.94% | 5.50% | ||
76 Outperform | ¥75.14B | 13.12 | 1.49% | 6.45% | 13.26% | ||
73 Outperform | ¥112.58B | 12.51 | 1.10% | 7.94% | 0.06% | ||
73 Outperform | ¥103.11B | 10.82 | 2.16% | 3.09% | 10.80% | ||
68 Neutral | ¥66.20B | 11.99 | 1.94% | 5.39% | 14.57% | ||
63 Neutral | $20.95B | 14.50 | -4.08% | 3.12% | 2.72% | -11.24% |
G-7 Holdings Inc. reported a 14.4% increase in net sales for the three months ending June 30, 2025, compared to the same period in the previous year. The company also saw a 22% rise in profit attributable to owners, indicating strong financial performance. The forecast for the fiscal year ending March 31, 2026, predicts continued growth with a 7.4% increase in net sales and a 15.4% rise in profit attributable to owners. These results and forecasts suggest a positive outlook for the company, potentially strengthening its market position and benefiting stakeholders.
G-7 Holdings Inc. has completed the payment process for the disposal of 16,000 treasury shares as restricted share-based remuneration, following a resolution by the Board of Directors. This move is aimed at aligning the interests of the company’s directors and subsidiaries with its long-term goals, potentially impacting its operational and strategic positioning.
G-7 Holdings Inc. announced the disposal of 16,000 treasury shares as restricted share-based remuneration, aiming to align the interests of its directors with shareholders by tying their compensation to stock performance. This initiative is expected to enhance corporate value and incentivize directors to contribute to the company’s growth, impacting both the company’s operational strategies and its appeal to stakeholders.
G-7 Holdings Inc. reported its consolidated financial results for the fiscal year ending March 31, 2025, showing an 11% increase in net sales to ¥214,129 million. Despite this growth, profit attributable to owners of the parent decreased by 4.6% to ¥4,939 million. The company anticipates further growth in the next fiscal year, forecasting a 7.4% increase in net sales and a 15.4% rise in profit attributable to owners. The inclusion of Bonne Sante Co., Ltd. in its consolidation scope marks a strategic expansion, potentially enhancing its market position and offering new opportunities for stakeholders.